TOPAbout TaihoFinancial Highlights

Financial Highlights

Taiho Pharmaceutical Co.,Ltd. and Subsidiaries Fiscal years 2010,2009,2008,2007 and 2006

Millions of yenThousands of U.S. dollars(Note)
Years ended201020092008200720062010
Mar. 31, 2011Mar. 31, 2010Mar. 31, 2009Mar. 31, 2008Mar. 31, 2007Mar. 31, 2011
For the Year:
Net sales¥123,581¥120,716¥91,027¥128,478¥131,739$1,488,934
Operating income15,77814,56411,58923,07228,831190,100
Net income12,12710,4648,06715,18324,074146,120
Research and development expenses30,26229,73522,43927,91127,424228,973
Percentage of net sales(%)24.5%24.6%24.7%21.7%20.8%24.7%
Capital expenditures5,8404,3961,4694,1335,60014,998
At Year-End:
Total assets¥354,882¥346,619¥334,290¥331,054¥326,254$4,275,694
Total shareholders'equity319,333313,019306,271299,895285,8753,847,389
Employees2,6222,6432,5132,5892,4682,622

Note : U.S. dollar amounts are translated from yen, for convenience only, at the rate of ¥83=US$1, the approximate exchange rate at March 31,2011.


Top of Page